Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of new variants on SARS-CoV-2 infectivity and neutralization: A molecular assessment of the alterations in the spike-host protein interactions
Mary Hongying Cheng, James Krieger, Anupam Banerjee, et al.
iScience (2022) Vol. 25, Iss. 3, pp. 103939-103939
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 118
Understanding Mutations in Human SARS-CoV-2 Spike Glycoprotein: A Systematic Review & Meta-Analysis
Reetesh Kumar, Yogesh Srivastava, Pandiyan Muthuramalingam, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 856-856
Open Access | Times Cited: 31
InSty: a ProDy module for evaluating protein interactions and stability
Karolina Mikulska‐Ruminska, James Krieger, Anupam Banerjee, et al.
Journal of Molecular Biology (2025), pp. 169009-169009
Closed Access | Times Cited: 1
Surface charge changes in spike RBD mutations of SARS-CoV-2 and its variant strains alter the virus evasiveness via HSPGs: A review and mechanistic hypothesis
Zhongyun Zhang, Juan Zhang, Jiqiu Wang
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 31
Free Energy Perturbation Calculations of Mutation Effects on SARS-CoV-2 RBD::ACE2 Binding Affinity
Alina P. Sergeeva, Phinikoula S. Katsamba, Junzhuo Liao, et al.
Journal of Molecular Biology (2023) Vol. 435, Iss. 15, pp. 168187-168187
Open Access | Times Cited: 17
Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants
Zi-Sin Yang, Tzong-Shiun Li, Yu-Sung Huang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Gamma Delta T Cells and Their Involvement in COVID-19 Virus Infections
Georg von Massow, Steve Oh, Alan Tin‐Lun Lam, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 38
A new paradigm for molecular dynamics databases: the COVID-19 database, the legacy of a titanic community effort
Daniel Beltrán, Adam Hospital, Josep Lluis Gelpí, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D393-D403
Open Access | Times Cited: 14
Antibody drugs targeting SARS-CoV-2: Time for a rethink?
Likeng Liang, Bo Wang, Qing Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116900-116900
Open Access | Times Cited: 5
Structural evolution of Delta lineage of SARS-CoV-2
Mohammad Mahmoudi Gomari, Parastoo Tarighi, Edris Choupani, et al.
International Journal of Biological Macromolecules (2022) Vol. 226, pp. 1116-1140
Open Access | Times Cited: 21
Surfaces: a software to quantify and visualize interactions within and between proteins and ligands
Natália Teruel, Vinícius Magalhães Borges, Rafaël Najmanovich
Bioinformatics (2023) Vol. 39, Iss. 10
Open Access | Times Cited: 11
Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population
Doreen Lugano, Kennedy W. Mwangi, Bernard Mware, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population
Doreen Lugano, Kennedy W. Mwangi, Bernard Mware, et al.
Journal of Virology (2025)
Open Access
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
Natalia E. Ketaren, Fred D. Mast, Peter C. Fridy, et al.
eLife (2024) Vol. 12
Open Access | Times Cited: 3
Impact of the temperature on the interactions between common variants of the SARS-CoV-2 receptor binding domain and the human ACE2
Catherine Forest‐Nault, Izel Koyuturk, Jimmy Gaudreault, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Comparative Study of the Mutations Observed in the SARS-CoV-2 RBD Variants of Concern and Their Impact on the Interaction with the ACE2 Protein
Mariem Ghoula, Audrey Deyawe Kongmeneck, Rita Eid, et al.
The Journal of Physical Chemistry B (2023) Vol. 127, Iss. 40, pp. 8586-8602
Open Access | Times Cited: 8
Structural basis of G protein–Coupled receptor CMKLR1 activation and signaling induced by a chemerin-derived agonist
Xuan Zhang, T. Weiss, Mary Hongying Cheng, et al.
PLoS Biology (2023) Vol. 21, Iss. 12, pp. e3002188-e3002188
Open Access | Times Cited: 8
Point mutations in SARS-CoV-2 variants induce long-range dynamical perturbations in neutralizing antibodies
Dhiman Ray, Riley N. Quijano, Ioan Andricioaei
Chemical Science (2022) Vol. 13, Iss. 24, pp. 7224-7239
Open Access | Times Cited: 11
Role of the Pangolin in Origin of SARS-CoV-2: An Evolutionary Perspective
Shishir K. Gupta, Rashmi Minocha, Prithivi Jung Thapa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9115-9115
Open Access | Times Cited: 10
Chronicling the 3-year evolution of the COVID-19 pandemic: analysis of disease management, characteristics of major variants, and impacts on pathogenicity
Eleni Pitsillou, Yiping Yu, Raymond C. Beh, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3277-3298
Closed Access | Times Cited: 5
CoVEffect: interactive system for mining the effects of SARS-CoV-2 mutations and variants based on deep learning
Giuseppe Serna García, Ruba Al Khalaf, Francesco Invernici, et al.
GigaScience (2022) Vol. 12
Open Access | Times Cited: 9
Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern
Erika Rudi, Pablo Martín Aispuro, Eugenia Zurita, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
SARS-CoV-2 Delta Variant: Interplay between Individual Mutations and Their Allosteric Synergy
Chun Chan, Yi Song, Z. Xu, et al.
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1742-1742
Open Access | Times Cited: 8
In Silico Therapeutic Study: The Next Frontier in the Fight against SARS-CoV-2 and Its Variants
Calvin R. Wei, Zarrin Basharat, Godwin C. Lang’at
Drugs and Drug Candidates (2024) Vol. 3, Iss. 1, pp. 54-69
Open Access | Times Cited: 1
SARS-CoV-2 S-Protein–Ace2 Binding Analysis Using Surface Plasmon Resonance
Jason Baardsnes, Béatrice Paul‐Roc
Methods in molecular biology (2024), pp. 71-87
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top